Commercial Medical Policies for MedRx
Bone Modifiers
- Denosumab Products (Prolia) UM Medical De-Identified Download PDF
- Denosumab Products (Xgeva) UM Medical De-Identified Download PDF
Botulinum Toxins
Complement Inhibitors
Dermatology - Gene Therapy
Enzyme Replacement Therapy
Gaucher Disease - Enzyme Replacement Therapy
- Cerezyme UM Medical De-Identified Download PDF
- Elelyso UM Medical De-Identified Download PDF
- Vpriv UM Medical De-Identified Download PDF
Hematology - Gene Therapy
- Casgevy UM Medical De-Identified Download PDF
- Lyfgenia UM Medical De-Identified Download PDF
- Zynteglo UM Medical De-Identified Download PDF
Hemophilia - Non-Factor Routine Prophylaxis Products
Immunologicals
- Cinqair UM Medical De-Identified Download PDF
- Fasenra UM Medical De-Identified Download PDF
- Nucala UM Medical De-Identified Download PDF
- Xolair UM Medical De-Identified Download PDF
Inflammatory Conditions
- Entyvio Intravenous UM Medical De-Identified Download PDF
- Ilumya UM Medical De-Identified Download PDF
- Skyrizi Intravenous UM Medical De-Identified Download PDF
- Tocilizumab Intravenous Products UM Medical De-Identified Download PDF
- Tremfya Intravenous UM Medical De-Identified Download PDF
- Ustekinumab Intravenous Products UM Medical De-Identified Download PDF
Metabolic Disorders - Primary Hyperoxaluria
Neurology
-
Gene Therapy
- Imaavy UM Medical De-Identified Download PDF
- Rystiggo UM Medical De-Identified Download PDF
- Vyvgart Hytrulo UM Medical De-Identified Download PDF
- Vyvgart Intravenous UM Medical De-Identified Download PDF
Oncology (Injectable - Programmed Death Receptor-1)
Oncology (Intravesical)
Ophthalmology
-
Vascular Endothelial Growth Factor Inhibitors
-
Gene Therapy